By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NeuroDerm Ltd. 



Ofakim      Israel
Phone: 925-270-0519 Fax: 925-290-1209


SEARCH JOBS


Industry
Pharmaceutical






Company News
NeuroDerm Ltd. Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6/19/2013 10:34:35 AM
NeuroDerm Ltd. Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinson's Disease and Movement Disorders 6/13/2013 6:37:07 AM
NeuroDerm Ltd. Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinson's Disease 6/3/2013 10:54:32 AM
NeuroDerm Ltd. to Present at the Jefferies and Co. 2013 Global Healthcare Conference in New York City 5/31/2013 9:40:20 AM
NeuroDerm Ltd. Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinson's Disease 4/15/2013 10:10:03 AM
NeuroDerm Ltd. Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson's Disease 3/4/2013 9:43:19 AM
NeuroDerm Ltd. Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinson's Disease 11/9/2011 6:44:49 AM
NeuroDerm Ltd. Raises $2.5 Million in Series A Financing 7/23/2007 11:35:01 AM
//-->